Back to search

Belgium· BE-AMP-SAM378716-00

Docetaxel Eugia 20 mg/ml

A docetaxel product containing docetaxel, registered in Belgium by Eugia Pharma (Malta). The same ATC class is registered in 16 of our 19 countries.

ATC L01CD02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedDocetaxel Eugia 20 mg/mlATCL01CD02REGISTER NO.BE-AMP-SAM378716-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Docetaxel is registered in 16 of 19 countries.

Countries holding a registration under ATC L01CD02 (docetaxel), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Docetaxel · ATC L01CD02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of docetaxel costs, country by country.

Normalised to the WHO defined daily dose (6.43 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Docetaxel · price per daily dose (6.43 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$21.58
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Docetaxel
Manufacturer
Eugia Pharma (Malta)
Country
Belgium (BE)
ATC code
L01CD02
ATC class
Docetaxel
Defined daily dose
6.43 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    2756799
  • be_apb
    0757013

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

662 interactions on record for docetaxel.

Graded by severity as the source publishes them — 69 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Docetaxel · interactions on record

662 records

  • 69 severe
  • 302 moderate
  • 21 minor
  • 270 info

Most severe, free to view

  • LonafarnibA16AX20severe
  • AmiodaroneC01BD01severe
  • DronedaroneC01BD07severe
  • ConivaptanC03XA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Docetaxel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All docetaxel products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Docetaxel Ebewe, Docetaxel Hikma
  • Bulgaria · Доцетаксел Булгермед, Доцетаксел Новамед
  • Czechia · Docetaxel Ebewe
  • Germany · Bendadocel, Doce
  • Denmark · Docetaxel Ebewe, Docetaxel Stada
  • Estonia · Docetaxel Ebewe
  • Spain · Docetaxel Aurovit, Docetaxel Aurovitas
  • Finland · Docetaxel Ebewe
  • France · Docetaxel Arrow, Docetaxel Hikma
  • United Kingdom (Northern Ireland) · Docetaxel Biotech Pharma, Docetaxel Hikma Farmacêutica (Portugal)
  • Greece · Demotaxel, Demotaxel Mono
  • Croatia · Docetaksel Teva, Docetaksel Zentiva
  • Hungary · Docetaxel Seacross
  • Ireland · Docetaxel Seacross Pharma (Europe)
  • Iceland · Docetaxel Accord, Docetaxel Kabi
  • Italy · Docetaxel Aurobindo, Docetaxel Hikma
  • Liechtenstein · Docetaxel Accord, Docetaxel Kabi
  • Lithuania · Docetaxel Ebewe, Docetaxel Sanoswiss
  • Luxembourg · Docetaxel Eugia
  • Malta · Docetaxel Hospira
  • Netherlands · Demotaxel Mono, Docetaxel Eugia
  • Norway · Docetaxel Accord, Docetaxel Ebewe
  • Poland · Docetaxel Ebewe
  • Portugal · Docetaxel Aurovitas, Docetaxel Hikma
  • Romania · Docetaxel Teva
  • Sweden · Docetaxel Actavis, Docetaxel Ebewe
  • Slovenia · Docetaksel Sandoz
  • Slovakia · Docetaxel Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e98f37e2-8aa0-4097-a9b7-46436b2f08d5
GET /v1/drugs/e98f37e2-8aa0-4097-a9b7-46436b2f08d5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Docetaxel Eugia  20 mg/ml",
  "name_fr": "Docetaxel Eugia  20 mg/ml",
  "name_nl": "Docetaxel Eugia  20 mg/ml",
  "amp_code": "SAM378716-00",
  "strengths": [
    "20.0000",
    "20.0000",
    "424.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Docetaxel",
    "Ethanol",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Docetaxel",
  "authorisation_numbers": [
    "BE378716"
  ]
}

See everything about docetaxel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.